Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3762454013 | Sulfabenzamide 184 mg and sulfacetamide sodium 144 mg and sulfathiazole 172 mg vaginal tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3762455014 | Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing sulfacetamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing sulfathiazole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing sulfabenzamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has active ingredient | Sulfabenzamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has active ingredient | Sulfacetamide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has active ingredient | Sulfathiazole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing sulfabenzamide and sulfacetamide and sulfathiazole | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has active ingredient | Bactericide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has manufactured dose form | Vaginal dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has manufactured dose form | Conventional release vaginal tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing sulfacetamide in vaginal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator value | 144 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Count of base of active ingredient | 3 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator unit | Tablet | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has basis of strength substance | Sulfacetamide sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has unit of presentation | Tablet | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has precise active ingredient | Sulfacetamide sodium | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Is a | Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator value | 172 | false | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has precise active ingredient | Sulfathiazole | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has presentation strength numerator value | 184 | false | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has precise active ingredient | Sulfabenzamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has basis of strength substance | Sulfabenzamide | true | Inferred relationship | Existential restriction modifier | 2 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Has basis of strength substance | Sulfathiazole | true | Inferred relationship | Existential restriction modifier | 3 | |
| Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) | Plays role | Antibacterial therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR